Market research
SYNC.LSE Syncona Limited
LSE GBP Financial Services
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 678M
- P/E ratio
- Not available
- Analyst target
- 202
- Dividend yield
- Not available
- Beta
- 0.36
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Financial Services
- Industry
- Asset Management
- ISIN
- GG00B8P59C08
- Market cap
- 678M
- P/E ratio
- Not available
- Analyst target
- 202
- Dividend yield
- Not available
- Beta
- 0.36
About
About Syncona Limited
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SYNC.LSE discussion.
5 years, 5 months ago
Syncona Limited is currently in a long term downtrend where the price is trading 11.7% below its 200 day moving average.
From a valuation standpoint, the stock is 66.2% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 17.9.
Finally, its free cash flow fell by 153.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Syncona Limited gets an overall score of 1/5.